ArticleArthroplasty today2026
Medial Unicompartmental Knee Arthroplasty Is Associated With Significant Reduction in Pain and Opioid Prescribing Patterns Compared to Total Knee Arthroplasty: A Retrospective Cohort Study of 9595 Knees.
Article in Arthroplasty today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Total knee arthroplasty (TKA) and medial unicompartmental knee arthroplasty (mUKA) are successful operations to treat knee osteoarthritis. While mUKA is associated with less postoperative pain, there is a paucity of literature exploring postoperative opioid consumption and prescribing patterns between these procedures. The objective of this study was to evaluate in-hospital opioid consumption and postoperative opioid prescribing patterns, in milligram morphine equivalents (MMEs), between patients undergoing primary unilateral mUKA vs TKA. Methods: A single-institution retrospective review of patients undergoing primary mUKA or TKA from 2019 to 2022 was performed. Patients were excluded if they lacked 90-day follow-up, used narcotics preoperatively, had a history of anxiety/depression, or underwent additional procedures within 90 days. Multivariable regression analysis assessed inpatient MME consumption, as well as discharge +90-day total MME prescribing patterns. Results: A total of 9595 patients were analyzed (720 mUKA; 8875 TKA). The mUKA cohort had an adjusted length of stay 25.4 hours shorter than the TKA cohort ( Conclusions: In this large contemporary series, mUKA was associated with significantly shorter length of stay, statistically significant but clinically similar hourly inpatient MME consumption, and decreased 90-day MME prescribing patterns compared to TKA. These findings highlight favorable perioperative opioid and resource utilization associated with mUKA within its established indications and may contribute to patient counseling regarding expected postoperative recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.